Received May 5, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | C47XX | — |
Hiberix liquid portion only administration (potential); Inappropriate dose of vaccine administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 4-month-old male patient who received Hib (Hiberix) (batch number C47XX, expiry date 20-OCT-2026) for prophylaxis. On 26-FEB-2026, the patient received Hiberix. On 26-FEB-2026, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: Hiberix liquid portion only administration (potential)) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 27-APR-2026 Healthcare provider wanted to know how to proceed with the patient that received only the diluent of Hiberix.; Sender's Comments: US-GSK-US2026057336:Same reporter/Different patient US-GSK-US2026057334:Same reporter/Different patient US-GSK-US2026057335:Same reporter/Different patient US-GSK-US2026057337:Same reporter/Different patient US-GSK-US2026057340:Same reporter/Different patient US-GSK-US2026057335:Same reporter/Different patient US-GSK-US2026057503:Same reporter/Different patient US-GSK-US2026057667:Same reporter/Different patient